Cromptons Healthcare, the historic Hampshire based manufacturer and supplier of healthcare garments, textiles and patient handling equipment, has been snapped up.
MIP UK, The British subsidiary of Canadian healthcare products supplier MIP, has purchased the business for an undisclosed amount.
Tor Lund, President and Chief Executive of MIP, said it was an exciting time for employees of the firm, along with customers and other stakeholders.
Cromptonsâ history goes all the way back to 1926, with the company designing and supplying reusable and single use healthcare products, including patient positioning devices and garments, such as scrubs and patient gowns.
Based in Basingstoke, the firm supplies healthcare facilities and outsources laundry service providers throughout England, Scotland, Wales and Northern Ireland.
Martin Calhoun, Managing Director, said that MIP will serve the loyal employees and stakeholders of Cromptons well, and he has confidence that this combination will fortify their leading UK market position, while creating exciting opportunities for growth.
MIP President and Chief Executive, Lund, commented: “This is an exciting time for our employees, customers and other stakeholders. Over the past several years, our UK business has experienced strong growth in revenue and market share and our acquisition of Cromptons accelerates the execution of our long-term strategy in the UK.
“Cromptons is a well-recognized supplier in our market with a proud history of supplying quality products and providing outstanding service to its customers. We are very pleased to welcome the Cromptons’ team into the MIP family.”
MIP is a manufacturer and distributor of high performance textile and related products to healthcare facilities and distributors and outsourced laundry service providers.
The Company is a market leader in Canada and enjoys significant and growing market positions in the United States , United Kingdom and continental Europe.
MIP has manufacturing facilities in Quebec , China and Germany . MIP is owned by Banyan Capital Partners, a Canadian private equity group, and its senior management team.